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Strengths and limitations of this study
 ► This study will report on communication problems in 
language- mediated consultations in oncology set-
tings, as documented in the literature and as they 
occur in the clinical practice.
 ► The complementary methodologies that will be ap-
plied allow for a novel and fine- grained analysis of 
communication problems.
 ► Generalisability of findings to other languages and 
contexts should be carefully considered.
AbStrACt
Introduction Effective doctor–patient communication 
in oncology settings can be challenging due to the 
complexity of the cancer disease trajectory. The challenges 
can become greater when doctors and patients do not 
share a common language and need to rely on language 
mediators. The aim of this study is to provide evidence- 
based recommendations for healthcare professionals, 
patients and language mediators on how to interact with 
each other during language- mediated consultations in 
oncology settings.
Methods and analysis A systematic review of the 
literature on communication problems in monolingual and 
multilingual oncology settings will be conducted. Thirty 
language- mediated consultations with Turkish- speaking 
or Arabic- speaking cancer patients, language mediators 
and Dutch- speaking oncologists/haematologists will 
be video- recorded in three urban hospitals in Flanders, 
Belgium. All participants will be interviewed immediately 
after the consultation and 2 weeks after it by means of 
video- stimulated recall. Multimodal interaction analysis 
will be combined with qualitative content analysis to allow 
for the identification of communication practices when 
communication problems occur.
Ethics and dissemination The study has been approved 
by the following ethics committees: Ghent University 
Hospital, Antwerp University Hospital, Antwerp Hospitals 
Network (ZNA). Results will be published via (inter)national 
peer- reviewed journals and the findings of the study will 
be communicated using a comprehensive dissemination 
strategy aimed at healthcare professionals, patients and 
language mediators.
IntroduCtIon
Effective doctor–patient communication is an 
indicator of quality of care positively affecting 
adherence to treatment, the rate of recovery, 
as well as health outcomes and patient well- 
being.1–7 Conversely, poor or ineffective 
communication can lead to a decrease in 
patients’ understanding, an increase in anxiety 
or feelings of uncertainty, poorer compliance 
with treatment and lower general satisfaction 
with care.6 8–10 In oncology settings, due to 
the complexity of the cancer disease trajec-
tory (eg. disclosure of diagnosis, proposal of 
treatment plan, patient’s emotional experi-
ence), effective doctor–patient communica-
tion (often including family members) can 
be challenging.11–15
Due to the rising migration rates (258 
million international migrants in 2017),16 
growing numbers of patients in many 
parts of the world do not share a common 
language with their healthcare provider and 
vice versa.17 Language discordance between 
healthcare professionals and patients might 
result in communication problems18 at the 
level of interaction during the medical 
encounter, which, by extension, can lead 
to misunderstandings regarding diagnosis, 
prognosis and treatment, might impede 
building a doctor–patient relationship of 
trust and might, at times, even lead to expe-
riences of discrimination.19–23
In a bid to to overcome language barriers 
and prevent communication problems, 
family members, friends and healthcare staff 
who are fluent in the language of the host 
healthcare system translate for patients and 
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Table 1 Frequently used terms and their working definition
Term Working definition
Participants Patients, oncologists/haematologists, 
language- mediators
Communication 
problems
Lack of understanding/misunderstanding 
among participants in the medical 
consultation
Interactional 
processes
The ways in which participants in the 
medical consultation interact with each 
other by employing a wide range of 
semiotic resources
(eg. using gestures to alert each other to 
misunderstandings)
Semiotic 
resources
Resources which participants in the 
medical consultation employ in order to 
co- construct meaning with each other and 
to relate to each other (eg. speech, gaze, 
body orientation, gestures)
Communicative 
processes
The ways in which participants in 
the medical consultation try to reach 
understanding (eg. seeking clarification, 
confirming understanding)
doctors. Although the contribution of these ad hoc inter-
preters might be crucial, the use of trained professional 
interpreters is recommended,24 yet it does not guarantee 
communication without problems either, such as the 
erroneous translation of medical terms.25
While studies have provided some evidence of commu-
nication problems arising from language discordance at 
the level of interaction,18 26–30 the literature points out that 
there is still a wide range of communication problems 
that needs to be explored.31–34 Particularly in oncology 
settings, the types of communication problems that arise 
from language barriers between patients and doctors, the 
ways in which they occur in the doctor–patient interac-
tion, the reasons underlying these problems, as well as 
their effect on the doctor–patient communication remain 
largely under- investigated.
In this study, we focus on (1) the occurrence of commu-
nication problems arising from language discordance 
between healthcare professionals and patients at the level 
of interaction, (2) the ways in, and the reasons for, which 
these communication problems occur at the level of 
interaction, as well as (3) the effects of these processes on 
interaction and co- construction of understanding among 
patients, healthcare professionals and language media-
tors during the delivery of care.
We do not touch on participants’ communication skills, 
namely their ability to communicate well. Instead, we 
depart from (1) the participants’ inability to communicate 
with each other as a result of the language discordance 
between them and (2) the interactional complexity that is 
introduced through the presence of a language mediator.
Study objective
The primary objective of this study is to provide a set of 
evidence- based recommendations for healthcare profes-
sionals, patients, carers and language mediators in 
oncology settings on how to interact with each other in 
language- mediated consultations. The recommendations 
will hopefully allow them to improve their own commu-
nication practices in interaction with each other, contrib-
uting in this way to the elimination of communication 
problems and to the optimisation of the provision of care 
in oncology settings.
Accompanying the study objective, the goals of the 
study are:
1. To identify communication problems in language- 
mediated consultations in oncology settings, as cur-
rently recorded in the existing literature (WHAT).
2. To gain practice- based insights into the interactional 
and communicative processes and semiotic resources 
which participants in consultations employ (HOW).
3. To gain practice- based insights into the reasons behind 
participants’ interactional and communicative process-
es and participants’ use of semiotic resources (WHY).
4. To gain practice- based insights into the impact of par-
ticipants’ interactional and communicative processes 
and of the use of semiotic resources on healthcare de-
livery (EFFECT).
The definitions of terms used frequently in the goals of 
the study are found in table 1.
outcomes
1. To develop a set of evidence- based and ready- to- use 
recommendations for cancer patients and their fami-
lies on communicating with their doctors through pro-
fessional language mediators throughout the disease 
trajectory.
2. To develop a set of evidence- based recommendations 
on language- mediated communication with cancer pa-
tients for healthcare professionals and language medi-
ators. These will be integrated into undergraduate and 
postgraduate programmes for medical students and 
interpreting students, as well as into courses designed 
for cultural mediators.
To display the interrelationships between the specific 
project activities and their intended outcomes, we provide 
an illustration of our outcome approach to logic model35 
(see figure 1).
Method and analysis
Design
This prospective, mixed- methods observational study 
allows for a novel and fine- grained analysis of commu-
nication between oncologists/haematologists and 
patients from an under- represented group in the litera-
ture, namely migrant patients with language barriers in 
oncology settings. We combine qualitative methodolo-
gies, such as multimodal interaction analysis36 37 and qual-
itative content analysis,38 with analysis using the Empathic 
Communication Coding System (ECCS)39–41 in which a 
priori categories that are typically associated with quantita-
tive methods are used. The above combination allows for 
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Figure 1 Logic model describing specific activities and intended outcomes.
a comprehensive and fine- grained analysis of authentic, 
naturally occurring doctor–patient interactions that go 
beyond the mere identification and description.
At the outset of the study, we will conduct a system-
atic literature review on communication problems in 
oncology consultations. Although we draw on the avail-
able evidence previous studies on language discordant 
and interpreter- mediated communication in healthcare 
settings have provided,24 42 43 in this study we will narrow 
down the focus of the literature review to communi-
cation with cancer patients alone. The review will be 
conducted according to the Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses guidelines.44 
Relevant publications will be searched in PubMed, 
Embase, Web of Science and Google Scholar (the 
search strategies can be found in online supplemen-
tary files 1–3). The evidence that will be gathered from 
the literature will inform the subsequent collection of 
evidence (eg. interviews with oncologists/haematol-
ogists and patients immediately after the interview) 
and through the analysis of video- recorded consulta-
tions and video- stimulated recall (VSR) interviews. The 
combination of evidence from the available literature, 
the professional practice and participants’ perceptions 
will allow us to gain a deeper understanding of the 
occurrence of communication problems in language- 
mediated consultations in oncology settings, as well as 
of the ways in which, and the reasons why, they occur 
and their effect at the level of interaction.
In order to test the face validity of our findings and to 
prepare the recommendations, we will organise two focus 
group discussions with stakeholder groups.
Setting
The study will take place in three Belgian urban hospi-
tals in Ghent and Antwerp that cater for a large number 
of migrant patients who do not speak the host language 
(Dutch) and language mediators are called to enable 
communication between them and the Dutch- speaking 
healthcare professionals.
Sample
Considering this study to be primarily qualitative, we 
choose to rely on the concept of information power 
in order to appraise the sample size by relying on five 
items that determine sample size in qualitative studies, 
as proposed by Malterud et al45: study aim, sample 
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specificity, use of established theory, quality of dialogue 
and analysis strategy.
The scope of this study calls for a relatively large sample. 
We opt for purposeful sampling,46 meaning that the 
participants and size of the sample will be determined 
by predefined criteria, such as language combination, 
confirmed language mediator bookings and availability 
of all participants in the consultation, that are relevant to 
the study objective. Moreover, the scarcity of theoretical 
perspectives on communication problems in language- 
mediated consultations in oncology settings requires a 
relatively large sample. To the best of our knowledge, there 
are no theoretical perspectives on communication prob-
lems in the literature available when it comes to cancer 
communication in interpreter- mediated consultations. 
Recent systematic reviews of the literature on communica-
tion in language- discordant oncology settings have shown 
that most of studies are observational and do not offer 
theoretical perspectives on communication problems.47 
An initial appraisal of the sample can be estimated at 30 
video recorded consultations followed by 30 VSR- based 
interviews comprising 30 oncology patients, their oncol-
ogists/haematologists (approximately 20) and language 
mediators (approximately 10). The exact number of oncol-
ogists/haematologists and language mediators is subject to 
a number of factors, such as availability at the time of the 
scheduled consultation. The adequacy of the final sample 
size will be evaluated continuously during the research 
process and the appraisal of information power will be 
repeated along the process, supported by preliminary anal-
ysis, as recommended by Malterud et al.45 The data collec-
tion will start in 2020 and will end in 2021.
training prior to the data collection
We acknowledge that in qualitative studies, empirical data 
are co- constructed by complex interaction between the 
researcher and the study participants and that the research-
er’s experience, skills and personal qualities can shape 
the quality of interaction and thus the quality of data. The 
empirical data will be collected by a novice researcher (LV) 
who will receive training in the collection of primary data 
through interviews and video- recordings. The training will 
be provided by her supervisors (DK, PP), who have many 
years of experience in this research design. DK will train 
LV on the use of the ECCS48 as adapted for interpreter- 
mediated consultations and on multimodal interaction 
analysis.36
Eligibility criteria
Inclusion criteria
 ► Turkish- speaking or Arabic- speaking migrant cancer 
patients ≥18 years and their family members who 
reside in Flanders, attend consultations in oncology 
settings, do not speak Dutch and, therefore, require 
language support.
 ► Dutch speaking oncologists/haematologists in 
oncology wards requiring language support when 
holding consultations with the above patients.
 ► Professional language mediators with Dutch and 
Turkish/Arabic as working languages that are 
employed by the three hospitals as mentioned above 
in order to provide language support to the above 
patients and oncologists/haematologists.
recruitment
The recruitment of patients will occur consecutively (ie. 
each Turkish- speaking or Arabic- speaking patient sched-
uled to have a language- mediated consultation will be 
contacted). Access to the list of scheduled consultations 
will be granted by the Social Services department of each 
hospital and the participants’ (patients, family members, 
oncologists/haematologists, language mediators) written 
informed consent will be sought as outlined in the informed 
consent forms approved by the ethics committees of the 
above hospitals. This method of recruitment has been 
successfully used in previous studies at the same hospitals 
by members of our team.48 49
data collection
Gathering evidence from the available literature: systematic review
The review will focus on studies both in monolingual 
and language- mediated settings where communication 
is assessed at the level of the doctor–patient interaction 
and a value judgement has been assigned. The inclusion 
of monolingual consultations in the review will allow for 
the detection of communication problems in oncological 
consultations. The inclusion of mediated consultations will 
allow for the identification of communication problems 
that are inherent in language- mediated consultations.
The search strategy will be based on three concepts: 
oncology, communication problems, consultation/patient–
doctor interaction. We opt to replace “language- mediator” 
with the terms “interpreter”, “mediator” “language profes-
sional”, “translator” in our concepts as these are widely 
used in the literature as umbrella terms. The inclusion 
and exclusion criteria are defined as follows: (1) publi-
cations report on primary data, (2) all research designs 
will be considered, (3) studies with a title and abstract in 
English will be included, (4) time restrictions do not apply, 
(5) studies that report on participants’ own experiences 
with doctor–patient interaction in authentic consultations 
between adult cancer patients under treatment at various 
stages of the disease trajectory and their treating physicians 
will be included.
This review will allow us to register problems described in 
the literature to be experienced by patients and their fami-
lies, doctors and language mediators during consultations 
in oncology. A typology of categories of communication 
problems will be generated on completion of the literature 
review and will be used for an additional screening of the 
video- recorded consultations.
Gathering evidence from the professional practice: video 
recordings of language-mediated consultations
We will video record 10 mediated consultations in each 
of the above hospitals. In order to increase the likeli-
hood of all categories of communication problems being 
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captured as will have emerged from the systematic review 
of the literature, we will record consultations throughout 
the disease trajectory: at the beginning (eg. bad news 
delivery), during the disease trajectory (eg. shared 
decision- making on treatment) and at the end stage 
of disease (eg. discussing therapy failure and therapy 
discontinuation).
Gathering evidence from the professional practice: semi-structured 
interviews with oncologists/haematologists and patients
Immediately after the consultation, we will hold semi- 
structured interviews with the patients and the oncolo-
gists/haematologists. The interviews will allow us to gain 
insights into the doctors and patients’ understanding of 
the topics that were addressed during the consultation. 
Gaining insights into the doctors and patients’ under-
standing of the content of the consultation is particularly 
relevant when studying interpreter- mediated consul-
tations. This is because the consultation as perceived 
by the participants is reflective of what is spoken by the 
interpreter, which may be subtly different from what was 
spoken by the clinician and the patient in the first place.50 
Registering participants’ understanding of the content of 
the consultation immediately after the consultation will 
allow us to acquire a first overview of potential inconsis-
tencies in the patients and doctors’ understanding. These 
inconsistencies will be analysed further in greater detail at 
the subsequent levels of analysis.
Gathering evidence from patients, language mediators and 
doctors’ experience: VSR interviews
Two weeks after the consultation, we will measure partic-
ipants’ recall by relying on the Patient- Interpreter- 
Clinician coding (PICcode),50 a comprehensive 
and rigorous methodology for measuring recall in 
interpreter- mediated oncology consultations. In the 
second part of the interview, we will play back extracts of 
the consultation that present communication problems. 
We will invite the oncologists/haematologists, patients 
and language mediators to comment in their own 
language on their own and the others’ behaviour during 
individual semistructured VSR- interviews. The 2- week 
interval between the recording of the consultation and 
the VSR- interview will allow us to have the consultation 
transcribed in time, to have it translated and to have 
relevant excerpts selected which will be presented to the 
participants. The 2- week interval between the recording 
of the consultation and the VSR event is not unusual in 
the literature.49 51
PAtIEnt And PublIC InvolvEMEnt
This protocol was conceived without patient involvement. 
Patients were not invited to comment on the study design 
and were not consulted to develop patient relevant 
outcomes. Patients will be invited to interpret the results.
AnAlySIS
The following analytical steps are presented in chrono-
logical order.
First level of analysis: identification of inconsistencies 
in doctor–patient understanding of the content of the 
consultation (interviews after the consultation)
The research team will compare the patients and doctors’ 
input on their understanding of the contents of the 
consultation as it will emerge from the interviews that will 
be held immediately after the consultation. Inconsisten-
cies will be flagged and will be compared with the content 
of the actual doctor–patient interaction as shown in the 
video recording of the consultation.
Second level of analysis: assessment of various levels 
of equivalence and clinical relevance (transcribed video 
recorded consultations)
Further inconsistencies between doctors, language medi-
ators and patients’ utterances as shown in the video- 
recorded consultations will be analysed by LV using 
ELAN, a professional tool for the creation of complex 
annotations on video and audio data (http://www. mpi. 
nl/ corpus/ html/ elan/). The original utterances of the 
doctors and the patients as observed in the video record-
ings will be compared with the language mediators’ 
renditions into the other language during the consul-
tation. For the assessment of participants’ utterances in 
the source language and the language mediators’ rendi-
tions into the target language, Translation and Interpreting 
Studies scholars (LV, DK and colleagues) along with certi-
fied translators (based at KU Leuven) will perform an 
analysis by drawing on the concept of equivalence52 (1) 
at word and above wordlevel (lexical equivalence and 
collocations), (2) non- equivalence (the source language 
word expresses a concept which is unknown in the target 
language and culture), (3) at textual level (thematic, infor-
mation structures and cohesion), (4) pragmatic equivalence 
and implicature53 (what the speaker intended to commu-
nicate or what the speaker implied) and (5) semiotic equiv-
alence (what semiotic resources mean for participants in 
a given culture). The assessment of the different levels 
of equivalence between source language utterances and 
their renditions into the target language will be reviewed 
against clinical relevance (PP, JW). Inconsistencies in 
terms of equivalence and clinical relevance will be flagged 
and analysed further by means of multimodal interac-
tion analysis, in order to gain insights into the ways in 
which participants use their own and understand others’ 
semiotic resources and how they relate to each other in 
interaction.
third level of analysis: identification of inconsistencies in 
emotional talk (transcribed video-recorded consultations)
Considering that cancer communication involves 
addressing patient emotion1 54–56 and compromised 
emotional communication in language- mediated consul-
tations might lead to suboptimal communication,41 the 
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research team will identify different levels of emotional 
communication and will flag the language mediator’s 
effect on the expression and management of emotions 
(by noticing shifts in the patients’ emotion- laden state-
ments and the doctors’ levels of response to these). To this 
end, we will use the ECCS,39 40 as adapted for language- 
mediated consultations,57 in order to identify commu-
nication problems observed in the video recordings 
focusing on expression of, and response to, emotions.
The ECCS is a valid instrument for measuring empathic 
communication in monolingual physician- patient 
encounters and operationalises empathy as a transac-
tional process. The tool focuses on behavioural aspects 
of empathic communication and divides patient- initiated 
empathic opportunities into statements of emotion, prog-
ress or challenge. The adapted version of the ECCS will 
allow us to identify different levels of emotional commu-
nication. An analysis of equivalence and clinical relevance 
similar to the second level of analysis that will also be 
applied to informative/instructional talk will be applied 
to emotional talk in order to identify any inconsistencies 
in the patients’ emotion- laden statements, the language- 
mediators’ renditions and the doctors’ levels of response 
to the patients’ emotional talk.
Fourth level of analysis: multimodal analysis of instances 
in interaction where communication problems occur 
(transcribed video recorded consultations)
Considering that communication is a transactional 
process and patients, their family members attending the 
consultation, oncologists/haematologists and language 
mediators use a wide range of semiotic resources to this 
end, we will approach their interaction from the point 
of view of actions that carry communicative meaning58 
instead of taking only verbal interaction into account. 
Therefore, we will approach the coded instances of inter-
action where communication problems occur as outlined 
above by analysing the actual interaction in order to 
identify participants’ interactional processes in relation 
to each other and the semiotic resources they draw on 
when trying to reach understanding. Studying the ways 
in which participants use semiotic resources, such as 
speech, gaze, body orientation and gestures, allows us to 
gain insights into the participants’ culture as it becomes 
manifest through talk in interaction. Culture is a commu-
nicative phenomenon constituted through talk59 and 
language carries meanings that are not in the same sense 
because language is associated with culture and culture is 
more extensive than language.60
The previously coded instances of emotional communi-
cation (ECCS), where shifts are being identified in the level 
or content of emotional expression will at this stage serve as 
units of analysis in which LV and DK will analyse the partic-
ipants’ verbal and non- verbal actions during the consul-
tation. In order to do so, LV and DK will rely on existing 
analytical frameworks36 61 especially tailored to mediated 
consultations, while scrutinising the role of the participants’ 
gaze, body orientation, gesture and facial expressions. In 
this way, LV and DK will be able to investigate the ways in 
which gaze, body orientation, gestures and facial expres-
sions are employed by participants as semiotic resources 
in interaction36 61–63 (eg. complementing or contradicting 
the meaning of verbal interaction, used in parallel with, or 
separately from, verbal interaction or replacing the latter 
and so on). At the same time, the above analysis will allow 
us to observe the effect of all of the above agents’ use of 
semiotic resources and interactional and communicative 
processes during which healthcare is being delivered.
For the analysis of the above semiotic resources, the 
units of analysis, namely instances of interaction previ-
ously coded for emotion and information exchange, will 
be transcribed. Time- based transcripts will be realised 
with ELAN that will enable us to create, edit, visualise and 
search annotations for video and audio data. This type 
of multimodal analysis36 37 will allow us to gain further 
insights into the ways in which participants try to reach 
understanding in consultations on the cancer disease 
trajectory. In addition to that, it will allow us to observe 
the effect of participants’ behaviour in interaction on the 
process of healthcare delivery.
Fifth level of analysis: identification of categories of 
communication problems as registered in the literature
In order to capture a wider range of communication prob-
lems in the video- recorded consultations, the research 
team will screen them against the categories of commu-
nication problems that will emerge from the systematic 
literature review.
triangulation of data interpretation and preparation of 
dissemination of findings
Two focus group discussions for each stakeholders group 
(patients and family members, oncologists/haematolo-
gists and language mediators) will be conducted in the 
participants’ languages (5–10 participants per group) in 
order to test the validity of our findings and formulate a 
set of recommendations for patients, family members and 
integrate them in medical and interpreter education and 
training modules for cultural mediators. The focus groups 
will be facilitated by LV and at least one other member of 
the research team with experience in focus groups. The 
discussions will be audio- recorded and one of the facilita-
tors will be taking extensive notes. Every effort will be made 
to ensure gender balance. The first 10 min will consist of 
introductions and a brief overview of the background and 
purposes of the focus group. Participants will be granted 
access to the draft recommendations and will be asked to 
share their reflections on them and identify any items that 
might be ambiguous, confusing or difficult to understand 
and/or to implement. Participants’ body language, posture 
and voice tone will be documented in the observation notes 
and will be reviewed during the analysis of the data.64
EthICS And dISSEMInAtIon
The study has been approved by three independent 
ethics committees at the respective hospitals (Belgian 
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registration number: B670201940349). There are no risks 
associated with this study. Participants’ written informed 
consent will be sought prior to their inclusion in the 
study. Participants’ anonymity and privacy will be duly 
protected.
The findings of the study will be communicated using 
a comprehensive dissemination strategy aimed (1) at 
patients and their family members (eg. brochure to be 
made available on the website of Stand Up To Cancer, 
the Flemish Cancer Society and to be distributed to 
patient groups and patient organisations), (2) educators 
(eg. integration of findings in medical- and interpreter 
education and cultural mediator training), (3) clinicians 
(eg. presentation of findings at oncology wards in Flan-
ders, making findings available to the Belgian Society of 
Medical Oncology), (4) language mediators (eg. making 
findings available to the Belgian Chamber of Transla-
tors and Interpreters, to the Training and Certification 
Unit for Public Service Interpreting and Translation at 
the Flanders Integration Agency; to the Federal Public 
Service for Health, Food Chain Safety and Environ-
ment that distributes language/cultural mediators to the 
Belgian hospitals), (5) policy makers (eg. making find-
ings available to hospital boards). At the same time, the 
results of the study will be published in national and inter-
national, peer- reviewed journals and presented at inter-
national conferences.
lIMItAtIonS
Despite the complementary methodologies that will be 
used and the fine- grained analysis that will be applied 
to primary data, we do acknowledge that this study will 
provide only limited insights into the complexity of 
communication problems in language- mediated consulta-
tions with migrant oncology patients. In addition, gener-
alisability of findings to other languages and contexts 
should be carefully considered.
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